تحميل
NASDAQHealthcareBiotechnology
أحدث البيانات المتاحة
9.80 US$
+0.05 US$ · +0.51%
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.
الإغلاق السابق
9.80 US$
+0.05 US$ · +0.51%
بعد ساعات التداول
9.80 US$
0.00 US$ · 0.00%
9 أكتوبر، 7:30 م ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.
نطاق اليوم
السعر الحالي 9.80 US$
نطاق 52 أسبوعًا
السعر الحالي 9.80 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
64
أقل من القيمة
المشاعر
64
صعودي
المخاطر
46
مخاطر أعلى من المعتاد
الزخم
77
زخم متزايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.
نطاق اليوم
السعر الحالي 9.80 US$
نطاق 52 أسبوعًا
السعر الحالي 9.80 US$
صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI1.77 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard Extended Market ETFVXF773.28 ألف0.00%95.4 مليار USD0.05%235 US$+0.80%
iShares Micro-Cap ETFIWC194.86 ألف0.01%1.32 مليار USD0.60%183 US$+0.11%
Dimensional - US Core Equity 2 ETFDFAC180.3 ألف0.00%88.6 مليار USD0.21%45.33 US$+0.49%
Dimensional - US Targeted Value ETFDFAT73.4 ألف0.00%30.12 مليار USD0.33%67.27 US$-0.43%
U.S. Vector Equity Portfolio ETF Class SharesDXUV29.22 ألف0.00%6.18 مليار USD0.26%68.28 US$+0.25%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR23.11 ألف0.00%45.59 مليار USD0.17%84.44 US$+0.44%
U.S. Micro Cap Portfolio ETFDFMC17.19 ألف0.00%7.56 مليار USD0.43%57.813 US$+0.20%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Micro-Cap ETFIWCDimensional - US Core Equity 2 ETFDFACDimensional - US Targeted Value ETFDFATU.S. Vector Equity Portfolio ETF Class SharesDXUVU.S. Core Equity 1 Portfolio ETF Class SharesDCORU.S. Micro Cap Portfolio ETFDFMCالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
